| 期刊全稱 | Antirheumatic Therapy: Actions and Outcomes | | 影響因子2023 | Richard O. Day,Daniel E. Fürst,Barry Bresnihan | | 視頻video | http://file.papertrans.cn/159/158659/158659.mp4 | | 發(fā)行地址 | Comprehensive and well structured according to classes of agents.Includes an outlook on future molecular targets.International authorship | | 學(xué)科分類 | Progress in Inflammation Research | | 圖書封面 |  | | 影響因子 | Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short- term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor- der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi- cian‘s opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long- term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2) | | Pindex | Book 2005 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-27 05:27
發(fā)表于 2025-3-21 18:01:21
